Jim Hickey’s American Politics

Let's Get Real.

Cancer Treatment Centers of America Provides Custom Oncology Options Through Clinical Pathways

Cancer Treatment Centers of America (CTCA) has long looked for ways to implement a custom platform that provides physicians with the information necessary to treat cancer patients in ways that they will be most responsive to. By forming a partnership with Allscripts and NantHealth, Clinical Pathways aims to be that technological solution that helps clinics increase their efficacy without disrupting daily workflow and the administration of treatment.

By collecting data from hundreds of oncologists across the U.S., and emerging research on cancer treatment, Clinical Pathways significantly reduces the amount of time spent guessing which treatment options work best by narrowing the focus of physicians. This increases the potential for recovery by choosing options that are best suited for individual patients during the first round of treatments.

This process increases transparency, not just between the clinics that apply Clinical Pathways into their treatment options, but in empowering patients with information that more directly relates to their health needs. Patients can now more easily compare their options with physicians while developing a more nuanced understanding of their specific diagnosis. And they also contribute to the growing knowledge of cancer data other oncologists will be able to make sense of and further refine Clinical Pathways.

Clinical Pathways’s library of cancer data covers the administration of over 2,700 treatment options. This includes peer-reviewed research, including those collected by governments, that is carefully looked over by a team of oncology specialists that assured each entry meets CTCA’s standards.

About Cancer Treatment Centers of America:

Cancer Treatment Centers of Amcerica is a network of hospitals across the U.S. that provides treatment to adults suffering from cancer. From its headquarters in Boca Raton, Florida, CTCA leads in genomic testing and precision treatment so patients get the most out of surgery, immunotherapy, and chemotherapy. This creates an atmosphere that’s conducive to recovery.

CTCA administers treatment to patients from its five facilities in Phoenix, Tulsa, Chicago, Philadelphia, and Atlanta. With a staff committed to the patient experience, CTCA has consistently maintained the praise of the medical community for the treatment they provide and the access of information they extend to their families so the best treatment options can be considered.

Comments are closed.